Hu XH - Search Results

1

Upregulation of HOXA11 during the progression of lung adenocarcinoma detected via multiple approaches.

Yang X, Deng Y, He RQ, Li XJ, Ma J, Chen G, Hu XH. Yang X, et al. Among authors: hu xh. Int J Mol Med. 2018 Nov;42(5):2650-2664. doi: 10.3892/ijmm.2018.3826. Epub 2018 Aug 14. Int J Mol Med. 2018. PMID: 30106131 Free PMC article.

2

Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study.

Gao L, Li SH, Tian YX, Zhu QQ, Chen G, Pang YY, Hu XH. Gao L, et al. Among authors: hu xh. Onco Targets Ther. 2017 Jul 20;10:3667-3683. doi: 10.2147/OTT.S137433. eCollection 2017. Onco Targets Ther. 2017. PMID: 28790856 Free PMC article.

3

The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model.

He RQ, Li XJ, Liang L, Xie Y, Luo DZ, Ma J, Peng ZG, Hu XH, Chen G. He RQ, et al. Among authors: hu xh. BMC Cancer. 2017 Sep 19;17(1):655. doi: 10.1186/s12885-017-3646-1. BMC Cancer. 2017. PMID: 28927388 Free PMC article.

4

Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining.

Chen WJ, Tang RX, He RQ, Li DY, Liang L, Zeng JH, Hu XH, Ma J, Li SK, Chen G. Chen WJ, et al. Among authors: hu xh. Oncotarget. 2017 May 22;8(37):61282-61304. doi: 10.18632/oncotarget.18058. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977863 Free PMC article.

5

Effect of miR‑146a‑5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation.

Huang WT, Cen WL, He RQ, Xie Y, Zhang Y, Li P, Gan TQ, Chen G, Hu XH. Huang WT, et al. Among authors: hu xh. Mol Med Rep. 2017 Dec;16(6):8781-8792. doi: 10.3892/mmr.2017.7713. Epub 2017 Oct 4. Mol Med Rep. 2017. PMID: 28990079 Free PMC article.

6

Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature.

He RQ, Wei QJ, Tang RX, Chen WJ, Yang X, Peng ZG, Hu XH, Ma J, Chen G. He RQ, et al. Among authors: hu xh. Oncotarget. 2017 May 22;8(46):80336-80347. doi: 10.18632/oncotarget.18165. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113307 Free PMC article.

7

Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study.

Liang L, Zeng JH, Wang JY, He RQ, Ma J, Chen G, Cai XY, Hu XH. Liang L, et al. Among authors: hu xh. Pathol Res Pract. 2017 Dec;213(12):1494-1509. doi: 10.1016/j.prp.2017.10.001. Epub 2017 Oct 10. Pathol Res Pract. 2017. PMID: 29113686

8

Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report.

Ma FC, Yu Q, Zeng ZM, He RQ, Mo CH, Zhong JC, Ma J, Feng ZB, Chen G, Hu XH. Ma FC, et al. Among authors: hu xh. Onco Targets Ther. 2017 Nov 1;10:5237-5242. doi: 10.2147/OTT.S146051. eCollection 2017. Onco Targets Ther. 2017. PMID: 29138576 Free PMC article.

9

Clinical significance of high expression of miR-452-5p in lung squamous cell carcinoma.

Gan XN, Gan TQ, He RQ, Luo J, Tang RX, Wang HL, Zhou H, Qing H, Ma J, Hu XH, Chen G. Gan XN, et al. Among authors: hu xh. Oncol Lett. 2018 May;15(5):6418-6430. doi: 10.3892/ol.2018.8088. Epub 2018 Feb 20. Oncol Lett. 2018. PMID: 29616113 Free PMC article.

10

Prognostic Significance of LncRNA PVT1 and Its Potential Target Gene Network in Human Cancers: a Comprehensive Inquiry Based Upon 21 Cancer Types and 9972 Cases.

He RQ, Qin MJ, Lin P, Luo YH, Ma J, Yang H, Hu XH, Chen G. He RQ, et al. Among authors: hu xh. Cell Physiol Biochem. 2018;46(2):591-608. doi: 10.1159/000488627. Epub 2018 Mar 28. Cell Physiol Biochem. 2018. PMID: 29617692 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

556 results

Search Page

Filters